Labeler
Swedish Orphan Biovitrum AB (publ) NDC Codes
Swedish Orphan Biovitrum AB (publ) lists 15 finished drug products in the FDA NDC Directory under NDC labeler code 66658.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Emapalumab, Nitisinone, Palifermin, Anakinra, Palivizumab
- NDC labeler codes
- 66658
- Strengths
- Palifermin 5.16 mg/1.2mL; Emapalumab 50 mg/2mL; Emapalumab 100 mg/4mL; Emapalumab 250 mg/10mL; Emapalumab 500 mg/20mL; Emapalumab 100 mg/20mL; Emapalumab 10 mg/2mL; Emapalumab 50 mg/10mL; Nitisinone 2 mg/1; Nitisinone 5 mg/1; Nitisinone 10 mg/1; Nitisinone 20 mg/1; Nitisinone 4 mg/mL; Anakinra 100 mg/.67mL; Palivizumab 50 mg/.5mL
- Dosage forms
- Injection, Capsule, Injection, Solution, Injection, Powder, Lyophilized, For solution, Suspension
- Routes
- Intravenous, Oral, Subcutaneous, Intramuscular
- Drug classes (FDA established)
- Interferon gamma Blocker, 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor, Mucocutaneous Epithelial Cell Growth Factor, Interleukin-1 Receptor Antagonist, Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 16
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Kepivancepalifermin | Palifermin 5.16 mg/1.2mL | Injection, Powder, Lyophilized, For solutionIntravenous | 66658-113 | 66658-0113-03 | — |
| Gamifantemapalumab-lzsg | Emapalumab 50 mg/2mL | InjectionIntravenous | 66658-522 | 66658-0522-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 100 mg/4mL | InjectionIntravenous | 66658-523 | 66658-0523-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 250 mg/10mL | InjectionIntravenous | 66658-524 | 66658-0524-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 500 mg/20mL | InjectionIntravenous | 66658-525 | 66658-0525-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 100 mg/20mL | InjectionIntravenous | 66658-510 | 66658-0510-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 10 mg/2mL | InjectionIntravenous | 66658-501 | 66658-0501-01 | — |
| Gamifantemapalumab-lzsg | Emapalumab 50 mg/10mL | InjectionIntravenous | 66658-505 | 66658-0505-01 | — |
| Orfadinnitisinone | Nitisinone 2 mg/1 | CapsuleOral | 66658-102 | 66658-0102-60 | — |
| Orfadinnitisinone | Nitisinone 5 mg/1 | CapsuleOral | 66658-105 | 66658-0105-60 | — |
| Orfadinnitisinone | Nitisinone 10 mg/1 | CapsuleOral | 66658-110 | 66658-0110-60 | — |
| Orfadinnitisinone | Nitisinone 20 mg/1 | CapsuleOral | 66658-120 | 66658-0120-60 | — |
| Orfadinnitisinone | Nitisinone 4 mg/mL | SuspensionOral | 66658-204 | 66658-0204-90 | — |
| Kineretanakinra | Anakinra 100 mg/.67mL | Injection, SolutionSubcutaneous | 66658-234 | 66658-0234-0766658-0234-28 | — |
| Synagispalivizumab | Palivizumab 50 mg/.5mL | Injection, SolutionIntramuscular | 66658-230 | 66658-0230-01 | — |
Swedish Orphan Biovitrum AB (publ): common questions
- What is Swedish Orphan Biovitrum AB (publ)'s NDC labeler code?
- 66658. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Swedish Orphan Biovitrum AB (publ)?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.